Price (delayed)
$1.22
Market cap
$4.03M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$38.57
Enterprise value
-$1.93M
Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare ...
Highlights
MBIO's EPS has surged by 87% year-on-year and by 51% since the previous quarter
MBIO's net income has surged by 69% year-on-year and by 33% since the previous quarter
The quick ratio has soared by 104% QoQ but it fell by 20% YoY
Key stats
What are the main financial stats of MBIO
MarketValuationsEarnings
Shares outstanding
3.31M
Market cap
$4.03M
Enterprise value
-$1.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$16.25M
Net income
-$15.75M
EBIT
-$15.75M
EBITDA
-$14.92M
Free cash flow
-$11.41M
Per shareBalance sheetLiquidity
EPS
-$38.57
EPS diluted
-$38.57
Free cash flow per share
-$18.71
Book value per share
-$4.05
Revenue per share
$0
TBVPS
$15.27
Total assets
$9.31M
Total liabilities
$13.18M
Debt
$878,000
Equity
-$3.87M
Working capital
-$4M
Debt to equity
-0.23
Current ratio
0.68
Quick ratio
0.57
Net debt/EBITDA
0.4
MarginsEfficiencyDividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-159.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBIO stock price
How has the Mustang Bio stock price performed over time
Intraday
-6.15%
1 week
-8.27%
1 month
-24.69%
1 year
-96.89%
YTD
-86.21%
QTD
-2.4%
Financial performance
How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.25M
Net income
-$15.75M
Gross margin
N/A
Net margin
N/A
MBIO financials
MBIO's net income has surged by 69% year-on-year and by 33% since the previous quarter
MBIO's operating income has soared by 67% YoY and by 32% from the previous quarter
Growth
What is Mustang Bio's growth rate over time
MBIO growth chart
Valuation
What is Mustang Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Price to earnings (P/E)
MBIO's EPS has surged by 87% year-on-year and by 51% since the previous quarter
Price to book (P/B)
MBIO's equity has surged by 55% since the previous quarter
Price to sales (P/S)
Efficiency
How efficient is Mustang Bio business performance
MBIO's ROA is up by 18% from the previous quarter but it is down by 9% YoY
Dividends
What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBIO.
Financial health
How did Mustang Bio financials performed over time
Assets vs liabilities
Mustang Bio's total assets is 29% less than its total liabilities
The quick ratio has soared by 104% QoQ but it fell by 20% YoY
Mustang Bio's current ratio has surged by 70% QoQ but it has decreased by 8% YoY
Debt vs equity
The company's debt is 123% higher than its equity
The debt to equity has shrunk by 109% QoQ and by 101% YoY
The company's debt has shrunk by 65% YoY and by 11% QoQ
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.